Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

NCT04337580 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Refractory Cancer
Castration Resistant Prostatic Cancer

Interventions

DRUG: Omeprazole 80 mg twice daily

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]